Testing effectiveness (Phase 2)Study completedNCT02559570
What this trial is testing
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Who this might be right for
Functional Constipation in Children Ages 6-17 Years
Forest Laboratories 173